Announcements Trials

Browse Landscape

Status

Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Telangiectasis 1 Stomatitis 1 Rosacea 1 Port-Wine Stain 1 Neoplasms 1 Lung Neoplasms 1 Hemangioma 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

Carboplatin 49 Pemetrexed 38 Cisplatin 34 Radiotherapy 32 Docetaxel 31 Gemcitabine 25 Paclitaxel 24 Nivolumab 18 pembrolizumab 15 Etoposide 15 Radiosurgery 13 Erlotinib Hydrochloride 11 Bevacizumab 11 Magnetic Resonance Spectroscopy 10 Vinorelbine 9 Radiation 9 Cyclophosphamide 7 Gefitinib 6 Fluorodeoxyglucose F18 6 Celecoxib 6 durvalumab 5 atezolizumab 5 Oxaliplatin 5 Irinotecan 5 Immunoglobulin G 5 Drug Therapy 5 Disulfides 5 Dexamethasone 5 Chemotherapy, Adjuvant 5 vandetanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Neoplasms × Tomography, Optical Coherence × Clear all

NCT01039311 2013-02-01

OCT

University of Oklahoma

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡